Impella AIC consoles with software <10.1 and Impella 5.5 first-gen safety alert
Summary
The ANSM has been informed of a safety action by Abiomed concerning Impella AIC consoles with software versions prior to 10.1, when used with first-generation Impella 5.5 ventricular assist devices. Healthcare providers using these devices have received specific instructions from Abiomed.
What changed
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding Impella AIC consoles with software versions less than 10.1, specifically when associated with first-generation Impella 5.5 ventricular assist devices. This alert, registered under number R2606924, indicates a safety action initiated by the manufacturer, Abiomed. The specific nature of the safety concern and the affected units are detailed in a letter sent directly to the users concerned.
Healthcare providers utilizing these specific Impella console and device configurations should review the safety communication from Abiomed, which was distributed on March 16, 2026. While the ANSM is relaying the information, direct engagement with Abiomed for any questions or required actions is advised. The document does not specify immediate compliance deadlines or penalties but implies a need for prompt review and adherence to manufacturer guidance to ensure patient safety and device efficacy.
What to do next
- Review Abiomed's safety communication regarding Impella AIC consoles and Impella 5.5 first-gen devices.
- Contact Abiomed directly for any specific questions or required actions related to the safety alert.
Archived snapshot
Mar 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Information n° R2606924 destinée aux établissements de santé Cette action de sécurité est enregistrée à l’ANSM sous le n° R2606924. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité.
L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Abiomed.
Les utilisateurs concernés ont reçu le courrier ci-joint. Téléchargez le courrier de la société Abiomed (16/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.